Epithelial sodium channel blocker
Epithelial Sodium Channel Blockers (ENaC blockers) are a class of drugs that inhibit the Epithelial Sodium Channel (ENaC), a protein that facilitates sodium reabsorption in the kidneys. These drugs are primarily used in the treatment of hypertension and certain kidney diseases.
Mechanism of Action
ENaC blockers work by inhibiting the ENaC, a protein found on the apical membrane of the epithelial cells in the kidneys. This protein is responsible for the reabsorption of sodium ions from the urine, which is a crucial process in maintaining the body's fluid and electrolyte balance. By blocking the ENaC, these drugs reduce sodium reabsorption, leading to an increase in the excretion of sodium and water in the urine. This can help to lower blood pressure and reduce fluid overload in conditions such as congestive heart failure.
Clinical Uses
ENaC blockers are primarily used in the treatment of hypertension, particularly in patients who have not responded to other antihypertensive drugs. They can also be used in the management of certain kidney diseases, such as nephrotic syndrome, where they can help to reduce proteinuria and edema.
Examples
Examples of ENaC blockers include amiloride and triamterene. These drugs are often used in combination with other antihypertensive drugs, such as thiazide diuretics, to enhance their efficacy and reduce the risk of side effects.
Side Effects
The most common side effects of ENaC blockers are related to their diuretic effect and include increased urination, dehydration, and electrolyte imbalances. In rare cases, they can also cause hyperkalemia, a potentially serious condition characterized by high levels of potassium in the blood.
Future Research
Research is ongoing into the development of new ENaC blockers and their potential uses in other conditions, such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD